Your browser doesn't support javascript.
loading
Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
Hertoghs, Nina; Nijmeijer, Bernadien M; van Teijlingen, Nienke H; Fenton-May, Angharad E; Kaptein, Tanja M; van Hamme, John L; Kappes, John C; Kootstra, Neeltje A; Hahn, Beatrice H; Borrow, Persephone; Ribeiro, Carla M S; Geijtenbeek, Teunis B H.
Afiliação
  • Hertoghs N; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Nijmeijer BM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • van Teijlingen NH; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Fenton-May AE; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Kaptein TM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • van Hamme JL; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Kappes JC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Kootstra NA; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Hahn BH; Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA, United States of America.
  • Borrow P; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Ribeiro CMS; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Geijtenbeek TBH; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
PLoS One ; 14(12): e0226651, 2019.
Article em En | MEDLINE | ID: mdl-31856198

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células de Langerhans / HIV-1 / Interações Hospedeiro-Patógeno Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células de Langerhans / HIV-1 / Interações Hospedeiro-Patógeno Idioma: En Ano de publicação: 2019 Tipo de documento: Article